Top 5 Tips for Engaging Doctors on AI – INFOGRAPHIC

Most doctors are still unfamiliar with AI in healthcare, so clear, simple explanations matter. Position AI as a support tool that eases admin and improves workflows, rather than replacing clinicians. Real-world examples, strong regulatory and ethical safeguards, and low-risk trial opportunities can all help build trust. Download the Infographic

View

Mature Woman Experiencing Hot Flush From Menopause

Reaching the Right Prescribers – Lessons from a CPD Success Story

Jean Hailes for Women’s Health partnered with AusDoc to drive awareness and enrolments for its menopause CPD modules, using targeted content, eDMs and digital placements to reach time-poor GPs. The campaign demonstrates how precise targeting, relevant clinical content and a coordinated multi-channel approach can deliver strong engagement and measurable lead generation.

View

RACGP Hackathon 2026 Winners

New AI tool could coach doctors after every patient visit

An AI “supervisor” developed at the RACGP 2026 Hackathon highlights a new model for continuous GP development, delivering post-consultation feedback based on clinical notes. By prompting reflection, identifying blind spots, and suggesting targeted learning, it addresses the long-standing gap in supervision once doctors enter independent practice. For health tech, this signals a scalable opportunity in workflow-integrated education and decision support, particularly for platforms that embed into clinical systems and demonstrate measurable impact. For pharma, it points to a shift toward personalised, case-based engagement, where evidence and education are delivered in real clinical context rather than through traditional CPD channels.

View

Female Headache And Overworked In Workplace

Under Pressure: Why Doctor Burnout Demands a Rethink of Pharma and Health Tech Engagement

Doctor burnout is reshaping Australian medical practice, with rising administrative burden and time pressure affecting how doctors engage with industry. Traditional approaches that add complexity or consume time are increasingly misaligned with doctors’ needs. Clinicians are seeking concise evidence, practical tools, and support that reduces administrative load. Engagement that saves time and improves patient care is now far more valued than additional touchpoints. This article argues that pharma and health tech companies must redesign engagement to prioritise efficiency, clarity and practical clinical support if they want to remain relevant and trusted partners.

View

Woman With Child Checking In At Reception

How Practice Managers Shape Pharma’s Access to GPs

The Australian general practice landscape is changing and so should pharma’s playbook. For years, pharmaceutical companies have focused their energy on reaching doctors. But the real gatekeepers of access, time, and influence increasingly sit just outside the consulting rooms: Practice Managers. They may not prescribe drugs, but they decide who gets in the door, when, and on what terms. In a system under pressure, that power is only growing.

View

Children Therapist And Reading Lesson

From Product to Pathway: What ADHD Care in General Practice Really Needs from Pharma

ADHD is no longer peripheral to Australian general practice. Rising patient demand, prolonged specialist wait times, and growing public awareness mean GPs are now central to ongoing ADHD care. For pharmaceutical companies, this creates a clear opportunity, but also exposes the limits of traditional engagement models.

View

Building Trust Takes Time Blocks

Rebuilding Trust: The Strategic Imperative Pharma can no Longer Ignore

Doctors were clear that pharma delivers substantial scientific progress but equally clear that trust hasn’t kept pace. Addressing this gap between high innovation and low trust is exactly where the opportunity lies to reset the doctor–pharma relationship.

View